Agilent's purchase of Varian should give the company much more prominence in the QbD space. As Investor's Business Daily put it, "Varian's products are used to help design new therapeutic drugs, while Agilent's products help analyze the causes and cures for diseases."
Here are a couple white papers out from Agilent this year:
Using Design of Experiments for HPLC Method Development
Using Fiber Optics to Speed and Simplify Formulation and Method Development
--Paul Thomas
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment